CD44 and breast cancer: The CD44+/CD24− CSC population in breast cancer is associated with a mesenchymal phenotype, increased N-cadherin expression, decreased E-cadherin, and increased YAP, Twist, Snail, and Slug gene expression [53,56,57,58].